TG Branfalt

A Florida-based attorney has filed federal lawsuits against at least three cannabis companies in Michigan, claiming the companies sent unsolicited marketing text messages or automated phone calls without proper consent.

Arizona’s Secretary of State confirmed this week that the state’s campaign for a cannabis legalization ballot initiative had submitted enough valid signatures to appear the November ballot.

Cannabis workers at Cultivate Holdings, a vertically integrated cannabis company in Massachusetts, have voted to join the United Food and Commercial Workers Union Local 1445.

Sullivan University in Louisville, Kentucky has announced a new Introduction to Cannabis Studies online course for the coming semester.

A recent study by the Ottowa Hospital in Ontario, Canada suggests that cannabis use during pregnancy can increase the risk of autism.

A judge in Laramie County, Wyoming last week threw out drug trafficking charges against hemp growers who were accused by prosecutors of growing cannabis with plans to distribute.

Hemp entrepreneurs and advocates are suing the state of Texas over regulations that ban smokeable forms of hemp products, arguing that the ban is unconstitutional.

A military vet who was sentenced to life in prison for selling $30 worth of cannabis to an undercover Louisiana police officer was recently resentenced to time served and will be released from prison.

A New Jersey doctor has had his license suspended after officials accused him of “indiscriminately” authorizing medical cannabis for “thousands of patients.”

Arizona’s ballot initiative to legalize adult-use cannabis has survived a legal challenge by opponents and is expected to move forward to the official signature verification stage.

Michigan regulators ordered the recall of about 3,200 pre-rolls after an employee allegedly licked one of the pre-rolls while making the product.

A great-grandmother is suing Disney after she was arrested at the company’s Florida theme park last year for carrying hemp-derived CBD oil, which is legal under federal law.

South Africa Cabinet officials have advanced a bill legalizing the adult use of cannabis; the measure comes three years after a High Court ruling declared that cannabis prohibition was unconstitutional.

A recent survey of millennial and baby boomer cannabis consumers suggests that baby boomers use cannabis for medicinal purposes at twice the rate of millennials.

The 10th U.S. Circuit Court of Appeals in Denver has ruled that a drug conviction is not necessarily automatic grounds for deporting an immigrant who is in the U.S. on a green card.

The University of Pittsburgh has announced a 10-year research program with medical cannabis company Parallel (formerly Surterra Wellness).

Minnesota Sen. Tina Smith has proposed a federal legalization bill that would remove cannabis from the Controlled Substances Act and grant regulatory authority of the plant to the Food and Drug Administration.

Massachusetts regulators have eased restrictions on more than 600,000 cannabis vape products that were quarantined last November amid a national trend of vape-related lung injuries.

Officials in Thailand have approved a draft law that would allow farmers, health professionals, and medical patients to cultivate, produce, and export cannabis products.

A first-of-its-kind study published last month suggests that women who use cannabis on a regular basis experience higher rates of sexual satisfaction.

Police data from Albany, New York shows that 97 percent of cannabis arrests and tickets targeted Black people — mostly young men — despite Black people representing just under 30 percent of the city’s population.

Arizona Gov. Doug Rucey said the state’s ballot initiative to legalize cannabis is “a bad idea based on false promises” and that he will vote against the measure.

The SEC has filed charges against six people for allegedly defrauding more than 400 investors out of $25 million; the scheme supposedly took place between September 2017 and February 2019.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.